• Letter of the Week

    Letter Of The Week

    DISHEARTENING DEBATE ON MEDICAL MARIJUANA

    I spent Tuesday morning at the Capitol listening to the debate on the
    medical marijuana bill. It saddened me to find that so many of the
    representatives are so woefully behind times in their knowledge
    concerning medical studies of cannabis.

    One gentleman, who proclaimed himself a pharmacist, brought up
    arguments that have been refuted for years, including claiming that
    marijuana is an addictive drug. This gentleman, who didn’t mention
    his own personal struggles with both prescription drugs and alcohol,
    was happy to pontificate on a subject he knows nothing about. He
    even brought up the canard about cannabis being a gateway drug.

    These representatives have staff members to do research for them on
    topics they may not be familiar with. I wonder how many of them
    requested anyone to do a simple Internet search to find out the
    current information available on the subject. My guess is that they
    never asked because they didn’t want to know. I suspect the only
    source they used is the DEA, which is forbidden by law from saying
    anything positive about marijuana.

    Another gentleman’s main worry was, “What message are we sending to
    our children?” I will answer that question for him. When legislators
    turn their back on their own constituents, denying them a substance
    available to ease pain and suffering by using arguments they know —
    or should know to be false — our children lose all respect for them
    and decide to find out for themselves about drugs labeled dangerous,
    which leads to some dangerous experimentation.

    It is unfortunate that so many sick and dying people are deprived of
    one of the best medications known because of myths, willful ignorance
    and deliberate lies.

    Dennis M. Garland

    Chatham

    Pubdate: Fri, 3 Dec 2010

    Source: State Journal-Register (IL)

  • Cannabis & Hemp - Hot Off The 'Net

    As medical marijuana proliferates, pot prices decline

    Chris Morris, CNBC.com

    Recreational users of marijuana are seeing price cuts on the street thanks to the growing number of states that have approved the drug for medicinal use.

    The price of cannabis, of course, varies wildly — depending on the strain purchased, its potency and the parts of the plant. Top quality pot in New York, for example, costs nearly $442 per ounce, while low quality is just $161, according to one website that tracks costs, PriceofWeed.com.

    On the whole, though, prices have been dropping nationwide over the past three to four years.

    High Times magazine, in its October issue, declared “It’s a buyer’s market!”, noting that the average price per ounce nationwide had fallen $49 in the past month alone.

    Oregon boasts the country’s cheapest pot, with the price of a high quality ounce running $259.13, according to PriceofWeed.com, a site that uses crowd-sourcing methodology to track marijuana prices around the country. (Anonymous users who buy the drug on the street input what they paid — and for how much — and the site averages out prices for the state or territory.) Montana comes in second at $273.87 per ounce. Both states are among the 14 to have passed laws allowing the medicinal use of the drug.

    Georgia and Virginia are the states with the most expensive cannabis, both coming in at roughly $452 per ounce. Neither has legalized the drug in any form.

    Geographically, pot tends to be more expensive along the East Coast — with the exceptions of Florida and Maine. Users there generally pay $425 or more for high quality product Midwest tokers pay a bit less.. And Western marijuana users – from Colorado onward –pay the least (typically less than $400 per ounce).

    PriceofWeed.com is one of four sources insiders look to as they track the street price of pot. Allen St. Pierre, executive director of Norml (the National Organization for the Reform of Marijuana Laws) cites it as one his organization regularly monitors.

    The others are the official DEA pricing index (which St. Pierre says is the least accurate), High Times’ monthly Trans-High Market Quotations, and Weedmaps.com, which has employees call medical dispensaries weekly for price, potency, strain name and more and then determines pricing trends from that information.

    But even with the cost declines of the past few years, prices remain steep, which surprises some people.

    “The vexation for the customer has been that for years, the individuals who would pay [high costs for recreational pot] did so because suppliers had all these legal threats,” says St. Pierre. “As that has been removed, there has not been a commensurate reduction in prices.”

    That doesn’t mean it won’t happen, though.

    In California, the price of high-grade cannabis is down roughly 17% over the past 12 months — a trend that is likely to accelerate, due in part to changes in the business practices of marijuana farmers.

    “Ten to 20 yeas ago, the people who were, for lack of a better term, the migrant marijuana workers were paid in cash,” says St. Pierre. “Two or three years ago, they started getting paid in product … which they have trouble converting to cash, so they logically begin selling it illegally. People are walking to the dispensary with the mindset that they’re going to pay X dollars, then these workers will undercut that by 50%. That phenomenon is the equivalent of having a wholesaler stop people before they walk into a Wal-Mart.”

    The rise of city-sanctioned grow farms, like those being planned in Oakland, could also put pressure on street prices of pot, because it would substantially boost supply.

    And if more states pass medical marijuana laws and wider legalization efforts prove successful down the road, that should continue to impact prices.

    A recent California ballot initiative to legalize the sale and consumption of marijuana (as well as tax it) was defeated, partly because producers feared it would result in drastically lower prices.

    St. Pierre says Norml expects the price could eventually fall to something comparable to a pack of cigarettes.

  • Cannabis & Hemp - Hot Off The 'Net

    Marijuana Cuts Tumor Growth by 50%

    The active ingredient in marijuana cuts tumor growth in common lung cancer in half and significantly reduces the ability of the cancer to spread, say researchers at Harvard University who tested the chemical in both lab and mouse studies.

    They say this is the first set of experiments to show that the compound, Delta-tetrahydrocannabinol (THC), inhibits EGF-induced growth and migration in epidermal growth factor receptor (EGFR) expressing non-small cell lung cancer cell lines. Lung cancers that over-express EGFR are usually highly aggressive and resistant to chemotherapy.

    THC that targets cannabinoid receptors CB1 and CB2 is similar in function to endocannabinoids, which are cannabinoids that are naturally produced in the body and activate these receptors. The researchers suggest that THC or other designer agents that activate these receptors might be used in a targeted fashion to treat lung cancer.

    “The beauty of this study is that we are showing that a substance of abuse, if used prudently, may offer a new road to therapy against lung cancer,” said Anju Preet, Ph.D., a researcher in the Division of Experimental Medicine.

    Acting through cannabinoid receptors CB1 and CB2, endocannabinoids (as well as THC) are thought to play a role in variety of biological functions, including pain and anxiety control, and inflammation. Although a medical derivative of THC, known as Marinol, has been approved for use as an appetite stimulant for cancer patients, and a small number of U.S. states allow use of medical marijuana to treat the same side effect, few studies have shown that THC might have anti-tumor activity, Preet says. The only clinical trial testing THC as a treatment against cancer growth was a recently completed British pilot study in human glioblastoma.

  • Cannabis & Hemp - Hot Off The 'Net - International

    Fight To Legalize Cannabis In African Nation Lands In High Court

    By Steve Elliott   Friday, Dec. 3 2010

    ​A challenge to the marijuana laws of the southern African nation Swaziland is going all the way to the High Court. Dr. Ben Diamini wants cannabis legalized, and he has also called upon the Minister of Commerce, Industry and Trade to grant him a 10-year exclusive license to grow “dagga,” as the herb is called locallly.

    Dr. Diamini pointed out that in the past 5,000 years, no one has died of cannabis anywhere in the world. He wants to High Court to help him get an order allowing him to operate a cannabis processing factory and set up a marketing company, with all dagga growers in Swaziland as suppliers, reports Mtheto Lungu at Africa News. He said that his factory will then solicit orders from local and international pharmacies.

    Diamini said he would involve international research institutions to conduct research on processed and raw cannabis.

    Holding a doctorate in education and a bachelor of science degree with a major in chemistry, Diamini said cannabis is not a drug and is not addictive. He said it is neither intoxicating nor poisonous.

    Swaziland, home to one of the last pure Sativa strains in the world, is bordered by South Africa and Mozambique.

    ​Cannabis influences a person to sleep, Dr. Diamini said, but the person is never “unable to know what he is doing.” Diamini said that cannabis is safer than either alcohol or tobacco.

    “Unlike alcohol, cannabis users to not lose self control; massive amounts just send them to sleep,” Diamini said.

    “There has never been a single death directly linked to cannabis use in 5,000 years of history with hundreds of millions of users in the world,” Diamini said. “There is no toxic amount of cannabis. No animal has died of an overdose of cannabis.”

    “It is smoked, it is eaten and it is used as an antidote for cases of poisoning,” Diamini’s affidavit reads. “The question of the risk element attached to the use of cannabis will continue to be a matter for the experts, but irrespective of the answer, there exists no just reason to punish cannabis users or those who grow it.”

    Diamini is specifically challenging Section 151(1) of the Opium and Habit Forming Drugs Act of 1922.

    According to that section, “In this Act, unless the context otherwise requires, habit forming drug or drugs means and includes the following as herein defined — cannabis, dagga, instangu, Indian hemp, under whatever name it may be described, known, sold, supplied or otherwise referred to or dealt with, whether the whole or any portion of the plant and all extracts, tinctures or preparations or admixtures thereon.”

    The matter is still pending before the High Court.

    Swaziland, bordering South Africa on three sides and Mozambique in the east, is home to the Swazi strain of cannabis, one of the few pure sativa strains left in the world, according to OurWeed.

  • Letter of the Week

    Letter Of The Week

    THIS IS NOT THE GOOD FIGHT

    Re: “Perry backs drug war troops – Military should be an option if
    Mexico approves, he says, because stronger tactics needed,” Friday
    news story. Gov. Rick Perry wants to send American kids to Mexico to
    risk being seriously injured or killed fighting drug gangs.

    The reason for this fight is largely to keep these same kids from
    smoking a plant that has never killed anyone in 5,000 years of
    recorded use. In contrast, Portugal decriminalized all drugs in 2001
    and put the money saved on law enforcement into education and medical
    treatment.

    Crime, drug use by teenagers, HIV, overdoses and heroin use all declined.

    The percentage of Portuguese who have ever used marijuana dropped to
    the lowest in the European Union, 10 percent.

    The American rate is about 40 percent. What is Perry drinking?

    Suzanne Wills, Drug Policy Forum of Texas, Dallas

    Pubdate: Wed, 24 Nov 2010

    Source: Dallas Morning News (TX)

    Referenced: http://www.mapinc.org/drugnews/v10/n000/a061.html

  • Hot Off The 'Net - International

    Time for an Impact Assessment of Drug Policy

    All stakeholders in the debate on drug policy share the goal of maximising social, environmental, physical and psychological wellbeing. At a time of economic crisis, it is particularly important that drug policy expenditure is cost-effective. Yet despite the many billions of dollars in drug-related spending each year, there are significant concerns about the effectiveness of current approaches at the domestic and international level. The time has come to provide an objective mechanism for assessing the relative merits of different policy approaches, by developing a genuinely evidence-based Impact Assessment (IA) of Drug Policy that compares the impact of alternative policies on human development, human security and human rights.

  • Drug Policy - Question of the Week

    Is drug classification accurate?

    Drug Policy Question of the Week – 11-17-10

    As answered by Mary Jane Borden, Editor of Drug War Facts for the Drug Truth Network on 11-17-10. http://www.drugtruth.net/cms/node/3151

    Question of the Week: Is drug classification accurate?

    The National Institute on Drug Abuse has named this week, November 8th through November 14th, National Drug Facts Week.

    NIDA “encourage(s) teens to get factual answers from scientific experts about drugs and drug abuse.”

    NIDA’s publication for this event entitled, “Drugs: Shatter the Myths,” contains “Facts” for marijuana, tobacco, methamphetamine, prescription drugs, and “huffing.” A search of it for “alcohol” finds no fact for this substance that is used monthly by 10 million American teens aged 12-20. This publication also omitted facts concerning heroin, cocaine, and crack.

    Last week, the prestigious medical journal, The Lancet, published an article entitled, “Drug harms in the UK: a multicriteria decision analysis.” A panel of experts used this analysis technique to rate 20 different drugs on 16 total criteria of harm to the individual and harm to others.

    This study found alcohol to be the most harmful drug. Its harm to others was rated as almost twice that for heroin and crack cocaine that placed second and third in this category. Heroin, crack cocaine, and methamphetamine were scored as most harmful to the individual. Still, alcohol’s overall harm score was 50% higher than that for runners up heroin and cocaine, dwarfing the scores of the seventeen other drugs evaluated.

    It appears that the three drugs deemed to be most harmful in one of the most prestigious scientific journals — alcohol, crack cocaine, and heroin — were overlooked in NIDA’s official publication for National Drug Facts Week.

    The Lancet article sums up this omission concluding,

    “the present drug classification systems have little relation to the evidence of harm.”

    These facts and others like them can be found in the Drug Usage and Addictive Properties of Drugs chapters of Drug War Facts at www.drugwarfacts.org.

    Questions concerning these or other facts concerning drug policy can be e-mailed to [email protected]

  • Drug Policy - Hot Off The 'Net - International

    IV drug policy fails HIV patients: Red Cross

    The spread of HIV and AIDS among millions of people could be slowed if addicts who inject drugs were treated as medical patients rather than as criminals, the International Federation of the Red Cross said Friday.

    More than 80 per cent of the world’s governments “are inclined to artificial realities, impervious to the evidence that treating people who inject drugs as criminals is a failed policy that contributes to the spread of HIV,” the Red Cross said.

    An estimated 16 million people worldwide inject drugs, mainly because it delivers the fastest, most intense high, in what has become a growing trend on every continent, according to the Red Cross.

    The launch of the International Federation of the Red Cross’ 24-page report — essentially to promote a new strategy for nations to stop the spread of the virus among injecting drug users — comes in the week before World AIDS Day on Dec. 1.